Average Indexed Monthly Earnings (AIME)

Average Indexed Monthly Earnings (AIME) is a term used by the Social Security Administration to determine a person's retirement benefits. The AIME is calculated by taking the average of a person's highest 35 years of earnings, adjusted for inflation.

 

Here are some key features of the Average Indexed MonthlyEarnings:

 

·      AIME is used to calculate a person's SocialSecurity retirement benefits.

 

·      AIME is calculated by taking the average of a person's highest 35 years of earnings, adjusted for inflation.

 

·      The Social Security Administration uses the AIME to determine the Primary Insurance Amount (PIA), which is the amount of retirement benefits a person is entitled to.

 

·      The PIA is based on a formula that takes into account the AIME, the age at which a person starts receiving benefits, and other factors.

 

·      A person's AIME can be affected by factors such as work history, earnings, and inflation.

 

For example, let's say that Jane has worked for 40 years and earned an average of $50,000 per year. The Social Security Administration would use Jane's highest 35 years of earnings to calculate her AIME, adjusted for inflation. If Jane's AIME is determined to be $3,000, the Social Security Administration would use that number to calculate her PIA. Jane's PIA would depend on other factors, such as her age at which she starts receiving benefits.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.